Prognostic factors and survival in stomach cancer - Analysis of 15 years of data from a referral hospital in iran and evaluation of international variation

Onkologie

Volumn 34, Issue 4, 2011, Pages 178-182

  Khedmat, Hossein ^a   Panahian, Mohammad ^a   Mashahdian, Mehrdad ^a   Rajabpour, Mojtaba Vand ^b,c   Zendehdel, Kazem ^c,d  

^a Baqyiatallah University of Medical Sciences   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Karloinska Institute   (Sweden)

Author keywords

International; Iran; Prognostic factors; Stomach cancer; Survival

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN;

ADULT; ARTICLE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; ESOPHAGOJEJUNOSTOMY; FEMALE; FOLLOW UP; GASTRECTOMY; GEOGRAPHIC DISTRIBUTION; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; ROUX Y ANASTOMOSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; SURVIVAL RATE; TUMOR VOLUME;

FEMALE; HUMANS; INTERNATIONALITY; IRAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 79953644597     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000327007     Document Type: Article

References (13)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M: Cancer incidence in Tehran metropolis: the first report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med 2009; 12:15-23.
3. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, Yazdanbod A, Shokoohi B, Mashayekhi A, Arshi S, Majidpour A, Babaei M, Mosavi A, Mohagheghi MA, Alimohammadian M: Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer 2003;107:113-118. (Pubitemid 37100094)
4. Kunisaki C, Ishino J, Nakajima S, Motohashi H, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, Shimada H: Outcomes of mass screening for gastric carcinoma. Ann Surg Oncol 2006;13: 221-228. (Pubitemid 43157417)
5. Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakh- shan MH, Shokuhi B, Fuladi R, Malekzadeh R: Survival rate of gastric and esophageal cancers in Ardabil province, north-west of Iran. Arch Iran Med 2007;10:32-37. (Pubitemid 46188962)
6. Moghimi-Dehkordi B, Safaee A, Zali MR: Survival rates and prognosis of gastric cancer using an actuarial life-table method. Acsian Pacific J Cancer Prevention 2008;9:317-322.
7. Siewert JR, Bottcher K, Stein HJ, Roder JD: Relevant prognostic factors in gastric cancer: tenyear results of the German gastric cancer study. Ann Surg 1998;228:449-461. (Pubitemid 30194389)
8. Sadighi S, Raafat J, Mohagheghi M, Meemary F: Gastric carcinoma: 5 year experience of a single institute. Asian Pac J Cancer Prev 2005;6:195-196.
9. Zeraati H, Mahmoudi M, Kazemnejad A, Mohammad K: Postoperative survival in gastric cancer patients and its associated factors: a time dependent covariates model. Iranian J Publ Health 2006;35:40-46. (Pubitemid 44560550)
10. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K: D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359:453-462.
11. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P: Postoperative morbidity and mortality after d1 and d2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The surgical cooperative group. Lancet 1996;347:995-999. (Pubitemid 26112171)
12. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW, et al.: Randomised comparison of morbidity after d1 and d2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-748.
13. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P: Patient survival after d1 and d2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical co-operative group. Br J Cancer 1999;79:1522-1530. (Pubitemid 29116815)